Gerhard Bauer
Director/Board Member bij Sitem-Insel AG
Profiel
Gerhard Bauer is currently a Director at Sitem-Insel AG and Swiss Medtech.
Previously, he worked as the VP-Global Operations & Engineering Officer at Bausch & Lomb, Inc. He also worked as a Portfolio Manager at Raiffeisen Kapitalanlage-Gesellschaft mbH from 2002 to 2006.
From 2010 to 2020, he was the Head-Research, Development & Operations at Straumann Holding AG.
He also worked as a Principal at GlaxoSmithKline, Inc. Dr. Bauer holds a graduate and doctorate degree from Ludwig-Maximilians-Universität München.
Actieve functies van Gerhard Bauer
Bedrijven | Functie | Begin |
---|---|---|
Sitem-Insel AG | Director/Board Member | - |
Swiss Medtech | Director/Board Member | - |
Eerdere bekende functies van Gerhard Bauer
Bedrijven | Functie | Einde |
---|---|---|
STRAUMANN HOLDING AG | Chief Operating Officer | 01-05-2020 |
Raiffeisen Kapitalanlage-Gesellschaft mbH
Raiffeisen Kapitalanlage-Gesellschaft mbH Investment ManagersFinance Raiffeisen Kapitalanlage-Gesellschaft mbH (RKG) is the wholly-owned fund management subsidiary of Raiffeisen Bank International AG (VSE: RBI; ADR: RAIFY) in Austria. Founded in 1985, the firm is headquartered in Vienna and manages the Raiffeisenfonds fund range for institutional and individual investors. | Portfolio Manager-Equities | 26-09-2006 |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Corporate Officer/Principal | - |
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Chief Operating Officer | - |
Opleiding van Gerhard Bauer
Ludwig-Maximilians-Universität München | Doctorate Degree |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
STRAUMANN HOLDING AG | Health Technology |
Bedrijven in privébezit | 5 |
---|---|
Bausch & Lomb, Inc.
Bausch & Lomb, Inc. Medical SpecialtiesHealth Technology Bausch & Lomb, Inc. develops, manufactures, and markets eye health products. It offers over-the-counter supplements, eye care products, ophthalmic pharmaceuticals, contact lenses, lens care, ophthalmic surgical devices, and instruments. The company was founded by John Jacob Bausch and Henry Lomb in 1853 and is headquartered in Rochester, NY. | Health Technology |
Raiffeisen Kapitalanlage-Gesellschaft mbH
Raiffeisen Kapitalanlage-Gesellschaft mbH Investment ManagersFinance Raiffeisen Kapitalanlage-Gesellschaft mbH (RKG) is the wholly-owned fund management subsidiary of Raiffeisen Bank International AG (VSE: RBI; ADR: RAIFY) in Austria. Founded in 1985, the firm is headquartered in Vienna and manages the Raiffeisenfonds fund range for institutional and individual investors. | Finance |
GlaxoSmithKline, Inc.
GlaxoSmithKline, Inc. Pharmaceuticals: MajorHealth Technology GlaxoSmithKline, Inc. manufactures and markets pharmaceutical products. The company develops medicines to prevent infections that cause serious medical problems such as respiratory illnesses, diabetes, viral control, infections, and central nervous system disorders. The company is headquartered in Mississauga, Canada. | Health Technology |
Sitem-Insel AG | |
Swiss Medtech |